Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 254

1.

Extremely Well-Differentiated Papillary Thyroid Carcinoma Resembling Adenomatous Hyperplasia Can Metastasize to the Skull: A Case Report.

Pyo JY, Kim J, Choi SE, Shin E, Yang SW, Park CS, Kim SM, Hong S.

Yonsei Med J. 2017 Jan;58(1):255-258. doi: 10.3349/ymj.2017.58.1.255.

2.

RN1, a novel galectin-3 inhibitor, inhibits pancreatic cancer cell growth in vitro and in vivo via blocking galectin-3 associated signaling pathways.

Zhang L, Wang P, Qin Y, Cong Q, Shao C, Du Z, Ni X, Li P, Ding K.

Oncogene. 2016 Sep 12. doi: 10.1038/onc.2016.306. [Epub ahead of print]

PMID:
27617577
3.

MUC16 contributes to the metastasis of pancreatic ductal adenocarcinoma through focal adhesion mediated signaling mechanism.

Muniyan S, Haridas D, Chugh S, Rachagani S, Lakshmanan I, Gupta S, Seshacharyulu P, Smith LM, Ponnusamy MP, Batra SK.

Genes Cancer. 2016 Mar;7(3-4):110-24. doi: 10.18632/genesandcancer.104.

4.

The expression profiles of the galectin gene family in colorectal adenocarcinomas.

Gopalan V, Saremi N, Sullivan E, Kabir S, Lu CT, Salajegheh A, Leung M, Smith RA, Lam AK.

Hum Pathol. 2016 Jul;53:105-13. doi: 10.1016/j.humpath.2016.02.016.

PMID:
27001434
5.

LGALS3 and AXIN1 gene variants playing role in the Wnt/ β-catenin signaling pathway are associated with mucinous component and tumor size in colorectal cancer.

Korkmaz G, Horozoglu C, Arıkan S, Gural Z, Sağlam EK, Turan S, Özkan NE, Kahraman OT, Yenilmez EN, Düzköylü Y, Doğan MB, Zeybek U, Ergen A, Yaylım İ.

Bosn J Basic Med Sci. 2016 Feb 4;16(2):108-13. doi: 10.17305/bjbms.2016.721.

6.

Secretome protein signature of human pancreatic cancer stem-like cells.

Brandi J, Dalla Pozza E, Dando I, Biondani G, Robotti E, Jenkins R, Elliott V, Park K, Marengo E, Costello E, Scarpa A, Palmieri M, Cecconi D.

J Proteomics. 2016 Mar 16;136:1-12. doi: 10.1016/j.jprot.2016.01.017.

PMID:
26850699
7.

[Application value of fine needle aspiration and cell block in preoperative diagnosis of thyroid cancer and discrimination of follicular tumor].

Fang Q, Cai C, Chen H.

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2015 Aug;50(8):668-72. Chinese.

PMID:
26696207
8.

Serum Anti-Gal-3 Autoantibody is a Predictive Marker of the Efficacy of Platinum-Based Chemotherapy against Pulmonary Adenocarcinoma.

Yanagita K, Nagashio R, Ryuge S, Katono K, Jiang SX, Tsuchiya B, Nakashima H, Fukuda E, Goshima N, Saegusa M, Satoh Y, Masuda N, Sato Y.

Asian Pac J Cancer Prev. 2015;16(17):7959-65.

9.

CA-125, but not galectin-3, complements CA 19-9 for discriminating ductal adenocarcinoma versus non-malignant pancreatic diseases.

Coppin L, Benomar K, Corfiotti F, Cattan S, Renaud F, Lapere C, Leteurtre E, Vantyghem MC, Truant S, Pigny P.

Pancreatology. 2016 Jan-Feb;16(1):115-20. doi: 10.1016/j.pan.2015.10.008.

PMID:
26613889
10.

Defining the value of CD56, CK19, Galectin 3 and HBME-1 in diagnosis of follicular cell derived lesions of thyroid with systematic review of literature.

Dunđerović D, Lipkovski JM, Boričic I, Soldatović I, Božic V, Cvejić D, Tatić S.

Diagn Pathol. 2015 Oct 26;10:196. doi: 10.1186/s13000-015-0428-4.

11.

Chemoprevention of Azoxymethane-induced Colonic Carcinogenesis in Balb/c mice Using a Modified Pectin Alginate Probiotic.

Odun-Ayo F, Mellem J, Naicker T, Reddy L.

Anticancer Res. 2015 Sep;35(9):4765-75.

PMID:
26254367
12.

The Role of CD56 in Thyroid Fine Needle Aspiration Cytology: A Pilot Study Performed on Liquid Based Cytology.

Bizzarro T, Martini M, Marrocco C, D'Amato D, Traini E, Lombardi CP, Pontecorvi A, Fadda G, Larocca LM, Rossi ED.

PLoS One. 2015 Jul 17;10(7):e0132939. doi: 10.1371/journal.pone.0132939.

13.

Galectin 3 regulates HCC cell invasion by RhoA and MLCK activation.

Serizawa N, Tian J, Fukada H, Baghy K, Scott F, Chen X, Kiss Z, Olson K, Hsu D, Liu FT, Török NJ, Zhao B, Jiang JX.

Lab Invest. 2015 Oct;95(10):1145-56. doi: 10.1038/labinvest.2015.77.

14.

Cyclin D1 in well differentiated thyroid tumour of uncertain malignant potential.

Lamba Saini M, Weynand B, Rahier J, Mourad M, Hamoir M, Marbaix E.

Diagn Pathol. 2015 Apr 18;10:32. doi: 10.1186/s13000-015-0262-8.

15.

The Diagnostic Usefulness of HMGA2, Survivin, CEACAM6, and SFN/14-3-3 δ in Follicular Thyroid Carcinoma.

Jang MH, Jung KC, Min HS.

J Pathol Transl Med. 2015 Mar;49(2):112-7. doi: 10.4132/jptm.2015.01.31.

16.

Sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid: more aggressive than previously reported.

Quiroga-Garza G, Lee JH, El-Naggar A, Black JO, Amrikachi M, Zhai QJ, Ayala AG, Ro JY.

Hum Pathol. 2015 May;46(5):725-31. doi: 10.1016/j.humpath.2015.01.012.

PMID:
25754017
17.

Galectin-3 Shapes Antitumor Immune Responses by Suppressing CD8+ T Cells via LAG-3 and Inhibiting Expansion of Plasmacytoid Dendritic Cells.

Kouo T, Huang L, Pucsek AB, Cao M, Solt S, Armstrong T, Jaffee E.

Cancer Immunol Res. 2015 Apr;3(4):412-23. doi: 10.1158/2326-6066.CIR-14-0150.

18.

Prognostic significance of serum galectin-3 levels in patients with hepatocellular cancer and chronic viral hepatitis.

Ulu M, Alacacioglu A, Yuksel E, Pamukk BO, Bozkaya G, Ari A, Yuksel A, Sop G, Alacacioglu I.

Saudi J Gastroenterol. 2015 Jan-Feb;21(1):47-50. doi: 10.4103/1319-3767.151228.

19.

Extracellular matrix protein 1 regulates cell proliferation and trastuzumab resistance through activation of epidermal growth factor signaling.

Lee KM, Nam K, Oh S, Lim J, Kim YP, Lee JW, Yu JH, Ahn SH, Kim SB, Noh DY, Lee T, Shin I.

Breast Cancer Res. 2014 Dec 11;16(6):479. doi: 10.1186/s13058-014-0479-6.

20.

CXCR7 stimulates MAPK signaling to regulate hepatocellular carcinoma progression.

Lin L, Han MM, Wang F, Xu LL, Yu HX, Yang PY.

Cell Death Dis. 2014 Oct 23;5:e1488. doi: 10.1038/cddis.2014.392.

Items per page

Supplemental Content

Loading ...
Support Center